BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kimman ML, Rotteveel AH, Wijsenbeek M, Mostard R, Tak NC, van Jaarsveld X, Storm M, Wijnsma KL, Gelens M, van de Kar NCAJ, Wetzels J, Dirksen CD. Development and Pretesting of a Questionnaire to Assess Patient Experiences and Satisfaction with Medications (PESaM Questionnaire). Patient 2017;10:629-42. [PMID: 28357591 DOI: 10.1007/s40271-017-0234-z] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.8] [Reference Citation Analysis]
Number Citing Articles
1 Apedani DB, Koduah A, Druye AA, Ebu NI. Experiences of mothers with preterm babies on support services in Neonatal Intensive Care Unit of a mission hospital in Ghana. International Journal of Africa Nursing Sciences 2021;15:100366. [DOI: 10.1016/j.ijans.2021.100366] [Reference Citation Analysis]
2 Belousova OA, Groen AJ, Ouendag AM. Opportunities and barriers for innovation and entrepreneurship in orphan drug development. Technological Forecasting and Social Change 2020;161:120333. [DOI: 10.1016/j.techfore.2020.120333] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Homaei S, Banazadeh N, Roaei F, Ziaaddini H. Development and Psychometric Assessment of the Methadone Therapy Experiences Questionnaire among Patients under Treatment. Addict Health 2019;11:183-91. [PMID: 31839916 DOI: 10.22122/ahj.v11i3.241] [Reference Citation Analysis]
4 Moor CC, Heukels P, Kool M, Wijsenbeek MS. Integrating Patient Perspectives into Personalized Medicine in Idiopathic Pulmonary Fibrosis. Front Med (Lausanne) 2017;4:226. [PMID: 29326935 DOI: 10.3389/fmed.2017.00226] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 3.2] [Reference Citation Analysis]
5 Kaiser K, Yount SE, Martens CE, Webster KA, Shaunfield S, Sparling A, Peipert JD, Cella D, Rottinghaus ST, Donato BMK, Wells R, Tomazos I. Assessing Preferences for Rare Disease Treatment: Qualitative Development of the Paroxysmal Nocturnal Hemoglobinuria Patient Preference Questionnaire (PNH-PPQ©). Patient Prefer Adherence 2020;14:705-15. [PMID: 32308375 DOI: 10.2147/PPA.S233830] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
6 Aronson KI, Suzuki A. Health Related Quality of Life in Interstitial Lung Disease: Can We Use the Same Concepts Around the World? Front Med (Lausanne) 2021;8:745908. [PMID: 34692737 DOI: 10.3389/fmed.2021.745908] [Reference Citation Analysis]
7 Kimman ML, Wijsenbeek MS, van Kuijk SMJ, Wijnsma KL, van de Kar NCAJ, Storm M, van Jaarsveld X, Dirksen CD; PESaM Collaborating Group. Validity of the Patient Experiences and Satisfaction with Medications (PESaM) Questionnaire. Patient 2019;12:149-62. [PMID: 30367435 DOI: 10.1007/s40271-018-0340-6] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
8 Shilbayeh SAR, Ismail SAER. Translation, Pilot Psychometric Validation, and Comparative Performance of the Arabic Version of the Anti-Clot Treatment Scale (ACTS). J Pharm Bioallied Sci 2021;13:61-8. [PMID: 34084049 DOI: 10.4103/jpbs.JPBS_395_20] [Reference Citation Analysis]
9 Swigris JJ, Brown KK, Abdulqawi R, Buch K, Dilling DF, Koschel D, Thavarajah K, Tomic R, Inoue Y. Patients' perceptions and patient-reported outcomes in progressive-fibrosing interstitial lung diseases. Eur Respir Rev 2018;27:180075. [DOI: 10.1183/16000617.0075-2018] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 5.3] [Reference Citation Analysis]
10 Aronson KI, Danoff SK, Russell AM, Ryerson CJ, Suzuki A, Wijsenbeek MS, Bajwah S, Bianchi P, Corte TJ, Lee JS, Lindell KO, Maher T, Martinez FJ, Meek PM, Raghu G, Rouland G, Rudell R, Safford MM, Sheth JS, Swigris JJ. Patient-centered Outcomes Research in Interstitial Lung Disease: An Official American Thoracic Society Research Statement. Am J Respir Crit Care Med 2021;204:e3-e23. [PMID: 34283696 DOI: 10.1164/rccm.202105-1193ST] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
11 López-Torres López J, Rabanales-Sotos J, López-Torres Hidalgo MR, Milián García RM, López Martínez C, Blázquez Abellán G. Reliability and Validity of the Treatment Satisfaction with Medicines Questionnaire (SATMED-Q) in Persons with Arterial Hypertension. Int J Environ Res Public Health 2021;18:3212. [PMID: 33808854 DOI: 10.3390/ijerph18063212] [Reference Citation Analysis]
12 Moor CC, Mostard RLM, Grutters JC, Bresser P, Aerts JGJV, Dirksen CD, Kimman ML, Wijsenbeek MS. Patient expectations, experiences and satisfaction with nintedanib and pirfenidone in idiopathic pulmonary fibrosis: a quantitative study. Respir Res 2020;21:196. [PMID: 32703201 DOI: 10.1186/s12931-020-01458-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 2.5] [Reference Citation Analysis]